MAG
BLFS icon

Millrace Asset Group’s BioLife Solutions BLFS Stock Holding History

Millrace Asset Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-105,643
Closed -$1.72M – 70
2023
Q4 		$1.72M Buy
105,643
+56,726
+116% +$724K 1.7% 22
2023
Q3 		$676K Buy
+48,917
New +$771K 0.84% 51

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Millrace Asset Group's BLFS Position: Q1 2024 in Review

Millrace Asset Group sold out of BioLife Solutions (BLFS) in Q1 2024, closing a stake of 105,643 shares — an estimated $1.72M sold.

Millrace Asset Group first reported a position in BLFS in Q3 2023 and held it in 2 quarters. The position peaked at $1.72M in Q4 2023. 149 funds tracked by Wall St. Rank hold BLFS as of Q1 2024.

  • Millrace Asset Group reported no remaining BioLife Solutions position as of Q1 2024 after selling out during the quarter.
  • Millrace Asset Group sold 105,643 BioLife Solutions shares in Q1 2024, an estimated $1.72M.
  • Millrace Asset Group first reported a position in BioLife Solutions in Q3 2023 and held it in 2 quarters.
  • Millrace Asset Group's BioLife Solutions position peaked at $1.72M in Q4 2023.
  • 149 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2024.

Based on Millrace Asset Group's 13F filing for Q1 2024, filed 13 May 2024.